We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Fertility Chip Measures Sperm Concentration and Motility

By LabMedica International staff writers
Posted on 08 Nov 2011
A lab-on chip device has been developed that that can accurately count sperm and measure their motility. More...


The chip can be inserted into a compact device for one-off use and a home test kit will soon make it possible for men to test their sperm in a familiar environment.

A doctoral candidate at the University of Twente (Enshede, The Netherlands) developed the lab-on-a-chip measures sperm concentration. On the chip, sperm flow through a liquid-filled channel, beneath electrode "bridges." When a cell passes beneath one of these electrodes, there is a brief fluctuation in the electrical resistance. These events are counted. To test the reliability of the concentration measurements, microspheres were added to the liquid and the method was selective enough to distinguish sperm from microspheres. The system was also able to distinguish reliably white blood cells from other bodies. In addition to being an indicator of sperm quality, the white cell count provides important additional information to gynecologists.

The importance of the sperm concentration is that the fertility standard states that a milliliter of ejaculate should contain at least 20 million sperm. A second important aspect of fertility is motility. This too can be measured using the lab-on-a-chip. A small adjustment of the lab-on-a-chip is all that is needed to sort motile sperm from nonmotile sperm, after which both can be counted separately. By measuring sperm motility in this way, the chip offers a complete test.

Simple home test kits are already commercially available. These indicate whether the concentration is "above or below the standard value." However, these tests are too limited, as they do not give accurate concentration readings. Loes Segerink, the PhD student, has received a grant, as a first step towards establishing a company. This will provide her with a platform for refining the fertility chip and its accompanying read-out device into a market-ready product.

Related Links:
University of Twente



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.